Clare Kahn

Director, Solid Biosciences Inc.

Companies

Stoke Therapeutics, Inc.Board member Apr 7, 2026 to now¹
Solid Biosciences Inc.Board member Mar 4, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Solid Biosciences Inc. SLDB2,960 shares³$17.7K at $5.97Mar 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 11, 2025Bought 1,860 shares at $5.34 of Solid Biosciences Inc.³
Jun 7, 2024Bought 1,100 shares at $7.67 of Solid Biosciences Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStoke Therapeutics, Inc., Board member
2
SEC EDGARSolid Biosciences Inc., Board member
3
SEC EDGARSolid Biosciences Inc. shares after the filing of Mar 11, 2025
4
SEC EDGARForm 4 filed Jun 11, 2024